Drupal.behaviors.print = function(context) {window.print();window.close();}>
Trovagene Eyes $6.1M in Public Offering
January 31, 2013
Trovagene Eyes $6.1M in Public Offering
By
a GenomeWeb staff reporter
Full-text access for registered users only.
Existing users
login here
.
New to GenomeWeb?
Register here
quickly for free access.
Related Stories
Trovagene, PerkinElmer Ink Assay Development Deal Targeting Liver Cancer
April 26, 2013 / GenomeWeb Daily News
Trovagene's Q4 Revenues, Loss Rise
April 2, 2013 / GenomeWeb Daily News
Dx Focus: Trovagene's HPV-HR Assay; BioTheranostics' CancerType ID
March 28, 2013 / PCR Insider
Trovagene, MD Anderson Partner on Transrenal BRAF Mutation Detection
January 3, 2013 / PCR Insider
Trovagene Set to Offer Transrenal KRAS Assay on Bio-Rad dPCR System in January
November 29, 2012 / PCR Insider